Standard BioTools
Logotype for Standard BioTools Inc

Standard BioTools (LAB) investor relations material

Standard BioTools Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Standard BioTools Inc
Q4 2025 earnings summary24 Feb, 2026

Executive summary

  • Fourth quarter 2025 revenue from continuing operations was $23.8 million, with full year 2025 revenue at $85.3 million, both reflecting year-over-year declines.

  • Over $40 million in annualized cost savings were fully operationalized, supporting the path to positive adjusted EBITDA and cash flow by the end of 2026.

  • Approximately $550 million in cash and investments post-SomaLogic transaction, fueling inorganic growth strategy.

  • Net income for Q4 2025 was $13.9 million, a significant improvement due to a one-time, non-cash partial release of $38.4 million in deferred tax valuation allowance.

Financial highlights

  • Q4 2025 revenue declined 4% year-over-year; full year 2025 revenue declined 6% year-over-year.

  • Q4 2025 gross margin was 47.8% (non-GAAP: 50.3%), up from 45.8% (non-GAAP: 48.1%) in Q4 2024.

  • Full year 2025 gross margin was 49.9% (non-GAAP: 53.6%), up from 49.3% (non-GAAP: 53.3%) in 2024.

  • Q4 2025 operating expenses were $36.0 million, down 4% year-over-year; non-GAAP operating expenses were $27.8 million, down 1%.

  • Full year 2025 operating expenses were $152.8 million, down 11% year-over-year; non-GAAP operating expenses were $108.3 million, down 4%.

  • Adjusted EBITDA loss for Q4 2025 was $15.8 million, a 3% improvement year-over-year; full year adjusted EBITDA loss was $62.6 million, also a 3% improvement.

Outlook and guidance

  • Fiscal year 2026 revenue expected in the range of $80 million to $85 million, with seasonality similar to prior years.

  • Management targets positive adjusted EBITDA and adjusted cash flow exiting 2026.

Detail path to positive adjusted EBITDA in 2026
How to reverse declining revenue trends in 2026?
Outline M&A strategy using cash and NOLs
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Standard BioTools earnings date

Logotype for Standard BioTools Inc
Q1 20265 May, 2026
Standard BioTools
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Standard BioTools earnings date

Logotype for Standard BioTools Inc
Q1 20265 May, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Standard BioTools Inc. (formerly known as Fluidigm Corporation) is a life sciences technology company that provides advanced tools and systems for biological research. The company specializes in products for mass cytometry, genomics, and other high-throughput techniques that enable researchers to study cell behavior, gene expression, and protein interactions at the molecular level. Standard BioTools' solutions support research in areas such as cancer, immunology, and drug discovery. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage